Fildena & FDA Crackdown on Drug Ads: Key Facts for 2025
In 2025, the U.S. Food and Drug Administration (FDA) launched an extensive crackdown on deceptive pharmaceutical advertising, reshaping the way erectile dysfunction (ED) medications, including Fildena, are promoted nationwide. This regulatory wave emphasizes truthful communication, transparent safety details, and stricter compliance standards. For patients, this shift means more reliable advertising and greater protection from misleading…
